Ambrogee

Ambrogee

Ambroxol HCI IP 15 mg + Guaiphenesin IP 50 mg Phenylephrine Hcl IP 5 mg + Chlorpheniramine Maleate I P 2 mg+Menthol IP 1 mg Syrup.
Pharmacotherapeutic Group:
Bronchodilator, Mucolytic and Expectorant Syrup

Packing: 100 ml

Indication

For the treatment of bronchospasm and reversible airways obstruction occurs in asthma, treat and relieve symptoms of cold and flu, mucolytic in the management of viscid mucoid secretions. associated with bronchitis, bronchiectasis and sinusitis.